# Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/progression-free-survival-and-safety-at-3-5-years-of-follow-up-results-from-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Antonio González-Martı́n,Bhavana Pothuri,Ignace Vergote,Whitney A. Spannuth Graybill,Domenica Lorusso,Colleen McCormick,Gilles Freyer,Floor Backes,Florian Heitz,Andrés Redondo,Richard G. Moore,Christof Vulsteke,Roisin E. O’Cearbhaill,Izabela A. Malinowska,Luda Shtessel,Natalie Compton,Mansoor R. Mirza,Bradley J. Monk |
| Citations | 115 |
| DOI | 10.1016/j.ejca.2023.04.024 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.ejcancer.com/article/S0959804923002253/pdf |
| OpenAlex ID | https://openalex.org/W4367845062 |
| PMID | 37263896 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)
- [Domenica Lorusso](https://scholariq.org/researchers/domenica-lorusso/)
- [Florian Heitz](https://scholariq.org/researchers/florian-heitz/)
- [Ignace Vergote](https://scholariq.org/researchers/ignace-vergote/)
- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)

## Paper funders

- [European Society for Medical Oncology](https://scholariq.org/funders/european-society-for-medical-oncology/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.